Aimei Health Technology Co., Ltd. (AFJKR) Common Equity (2023 - 2025)

Aimei Health Technology (AFJKR) has reported Common Equity for 3 consecutive years, with -$4.1 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Common Equity fell 174.87% year-over-year to -$4.1 million in Q4 2025; TTM through Dec 2025 was -$4.1 million, a 174.87% decrease from a year earlier, with the FY2025 full-year figure at $500.0 million, changed 0.0% from the prior year.
• Common Equity was -$4.1 million for Q4 2025 at Aimei Health Technology, down from -$3.4 million in the prior quarter.
• Over five years, Common Equity peaked at -$134124.0 in Q4 2023 and troughed at -$4.1 million in Q4 2025.
• A 3-year average of -$1.8 million and a median of -$1.5 million in 2024 frame the typical range for Common Equity.
• Across the five-year window, Common Equity tumbled 1000.93% in 2024 and plunged 174.87% in 2025, its largest moves.
• Over 3 years, Common Equity stood at -$134124.0 in 2023, then plunged by 1000.93% to -$1.5 million in 2024, then sank by 174.87% to -$4.1 million in 2025.
• The last three Common Equity figures came in at -$4.1 million (Q4 2025), -$3.4 million (Q3 2025), and -$2.9 million (Q2 2025), per Business Quant data.